Using intensity modulated radiation therapy (IMRT), doesn't harm the sexual function of prostate cancer patients, U.S. researchers say.

IMRT, a technique that more precisely targets the tumor is advancement in cancer treatment that is more successful as it improves the care that cancer patients receive

According to a new study on soy and fertility levels, the latest research discounts a previous study that linked soy with male low sperm count. The recent study by a Colorado researcher questions the conclusions of a Harvard study while toting the fact that Asian cultures have been consuming soy for generations.

The small scale, preliminary study that Dr. Jorge Chavarro from the Harvard School of Public Health in Boston was based on recollected intake of soyfoods and not on specific diets containing soyfoods

French pharmaceutical group Sanofi-Aventis has received a federal approval for its anti-cancer drug Taxotere.

The drug has been approved by the U.S. Food and Drug Administration to treat locally advanced head and neck cancer prior to chemoradiotherapy and surgery, Sanofi-Aventis said Monday

According to a recent study nearly a third of American adults take some type of multivitamin on a regular basis. In nearly every case, the goal is better health, even though there is no firm evidence to support this hope. However despite their not being firm data on benefits a 2007 report in the Journal of the National Cancer Institute concluded that there was an increased prostate cancer risk among men using multivitamins.

According to a Harvard Men's Health Watch report when scientists further explored the link to prostate finding, they found no link between multivitamin use and the risk of developing localized prostate cancer. Researchers noted that men who take multivitamins more than once a day were 32 percent are more likely to develop advanced prostate cancer and 98 percent more likely to die from the disease

A study by the Massachusetts Institute of Technology has found that a specific protein called Protein 4.1B might be helpful in restricting the spread of prostate cancer.

Researchers now say that Protein 4.1B can not only play an integral role in suppressing prostate cancer, but also in predicting the source of the disease. The scientists tracked their findings by injecting mice with prostate cancer tumors and compared the varied metastatic properties of its cells